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In the last years, there has been a growing interest in the application of different
non-invasive brain stimulation techniques to induce neuroplasticity and to modulate
cognition and behavior in adults. Very recently, different attempts have been made to
induce functional plastic changes also in pediatric populations. Importantly, not only
sensorimotor processing, but also higher-level functions have been addressed, with
the aim to boost rehabilitation in different neurodevelopmental disorders. However,
efficacy and safety of using these techniques in pediatric population is still debated.
The current article aims to review the non-invasive brain stimulation studies conducted
in pediatric populations using Transcranial Magnetic Stimulation or transcranial Direct
Current Stimulation. Specifically, the available proofs concerning the efficacy and
safety of these techniques on Autism Spectrum Disorder, Attention-deficit/hyperactivity
disorder, Dyslexia, Tourette syndrome, and tic disorders are systematically reviewed and
discussed. The article also aims to provide an overview about other possible applications
of these and other stimulation techniques for rehabilitative purposes in children and
adolescents.
Keywords: neurodevelopmental disorders, non-invasive brain stimulation, transcranial magnetic stimulation,
transcranial direct current stimulation, pediatric, rehabilitation, safety
INTRODUCTION
Non-Invasive Brain Stimulation (NIBS) techniques are widely used in healthy adults to investigate
brain mechanisms or to modify and enhance cognitive, behavioral, social, and emotional processes.
As well, NIBS are often used to boost neuropsychological or psychiatric rehabilitation, through
modulation of neuroplasticity. Having neuromodulatory properties, NIBS has been viewed as an
interesting tool to explore and to affect plasticity in a developing brain. Thus, the use of NIBS
has been recently proposed also in pediatric populations affected by brain disorders (Vicario and
Nitsche, 2013a; Palm et al., 2016; Hameed et al., 2017; Rivera-Urbina et al., 2017). In the last
decades, indeed, an increase in interest in the application of NIBS in the recovery and rehabilitation
of sensorimotor, executive functions, attention, and memory has been recorded. Remarkably,
researches on NIBS for the treatment and rehabilitation of clinical populations has focused not
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only on these main aspects of sensorimotor function and
cognition, but NIBS has considered to play a crucial role also
in addressing impairment in social cognition and behavior
(Boggio et al., 2015). The impact of neurodevelopmental
disorders is well-known, while the efficacy of the current
standard cognitive treatment and drugs medication is still
controversial. It is thus imperative to find and to assess the
effectiveness of new interventions and treatments. In this
review, we will describe the studies assessing the effects of
NIBS in treating neurodevelopmental disorders. In particular,
we will focus on Transcranial Magnetic Stimulation (TMS)
and transcranial Direct Current Stimulation (tDCS), with the
goal of underlying which are the advances in rehabilitation by
using NIBS, and to underline how NIBS techniques can be
useful to improve the quality of life in neurodevelopmental
disorders.
NON-INVASIVE BRAIN STIMULATION
TECHNIQUES
With NIBS, here we refer to two main techniques, namely TMS
and tDCS. TMS is based on the application of a magnetic field
that induces an electric field in the brain, via electromagnetic
induction. In order to induce the magnetic field, intense pulses
of electric current are delivered to a coil placed on participant’s
head. The induced electric field, in the brain, triggers action
potentials, and alters neural activity. The effects of TMS differs
depending on the place of the stimulation, mainly due to the
coil position, the intensity of stimulation, the frequency, and
the number of pulses. Basically, TMS can be delivered through
single or repetitive pulses. In this last case, repetitive TMS
(rTMS) can have excitatory or inhibitory effects, respectively,
with high (>5Hz; HF) or low frequency (e.g., 1Hz; LF) patterns
of stimulation (Maeda et al., 2000; Pascual-Leone et al., 2000;
Lefaucheur et al., 2014). Notably, to have more rapid and
long-lasting effects on neuroplasticity, rTMS can be further
patterned into higher-frequency (50Hz) trains of three pulses
every 200ms (Theta Burst Stimulation) that can be delivered
either continuously (cTBS), producing long lasting inhibitory
effects, or in intermittent 2-s trains every 10 s (iTBS) resulting
in long lasting excitation of the underlying cortex (Huang et al.,
2005).
Transcranial direct current stimulation (tDCS) is a type
of transcranial electrical stimulation (TES) consisting in the
application of constant weak current (1–2mA) to the brain via
electrodes applied on the skin of the scalp, in correspondence
of specific cortical region. Electric current passes between a
positively charged anode and a negatively charged cathode and
provokes a sub-threshold modulation of neuronal excitability
without depolarizing action potentials. In principle, this
modulation is polarity dependent and it consists in a change
toward depolarization (i.e., excitation) after anodal stimulation
or toward hyperpolarization (i.e., inhibition) after cathodal
stimulation (Priori et al., 1998; Nitsche and Paulus, 2000).
However, some exceptions of this rule exist, in light of possible
dose-dependent inversion of excitation (Batsikadze et al., 2013).
Furthermore, while the excitatory/inhibitory effects are well-
documented on the motor cortex, by measuring changes of
cortico-spinal excitability with the recording of motor potentials
evoked by single-pulse TMS, the generalization of the same
effects on other cortical areas should be taken with caution.
METHODS
Literature Search
The research question of this review was identified as follows:
“how do non-invasive brain stimulation techniques support
the rehabilitation of neurodevelopmental disorders?” From
this research question, to capture as many relevant citations
as possible, the keywords referring to the NIBS of interest
(repetitive transcranial magnetic stimulation; transcranial direct
current stimulation) were combined with the following keywords
referring to possible age and entries of the target population
(children, adolescent, pediatric, pediatric). Accordingly, the
search engine of the U. S. National Institute of Health
(Pubmed) was used to retrieve the literature with the
following search terms: “repetitive transcranial magnetic
stimulation + children”; “repetitive transcranial magnetic
stimulation + adolescent”; “repetitive transcranial magnetic
stimulation + pediatric”; “repetitive transcranial magnetic
stimulation+ pediatric”; “transcranial direct current stimulation
+ children”, “transcranial direct current stimulation +
adolescent”; “transcranial direct current stimulation+ pediatric”;
“transcranial direct current stimulation+ pediatric.”
These search terms retrieved a total of 451 hits for rTMS (110
+ 271 + 43 + 27) and 590 hits for tDCS (159 + 326 + 71 + 34)
studies. Finally, the reference list of previous review articles on
similar topics were checked (Vicario and Nitsche, 2013a; Palm
et al., 2016; Hameed et al., 2017; Rivera-Urbina et al., 2017),
leading to the inclusion of three more results.
The search for literature was performed of the 15th June 2018.
Inclusion and Exclusion Criteria
Only clinical trials and case reports assessing the effects of
NIBS on neurodevelopmental disorders were considered.
Disorders were included if listed in the DSM-5 category
of Neurodevelopmental disorders (American Psychiatric
Association, 2013). Review articles, meta-analyses, conference
abstracts, duplicates or non-English papers were excluded.
Furthermore, papers in which NIBS were used to identify
alteration in brain function were excluded. The total number
of papers for further screening was thereby reduced to 19 for
rTMS and 16 for tDCS (with one paper using both techniques),
addressing cognitive functions, and clinical symptoms in
autism spectrum disorder (ASD), Attention-deficit/hyperactivity
disorder (ADHD), Tourette syndrome (TS), and tic disorders,
and dyslexia. The studies are reported in Table 1.
ASD
ASD consists of several complex neurodevelopmental disorders,
featured by the presence of persistent impairments in social
communication and interaction, restricted and repetitive
patterns of behaviors or interests; onset is in the early
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developmental period, and the symptoms cause clinically
significant impairment in social, occupational, or other areas
of functioning (American Psychiatric Association, 2013). The
spectrum encompasses different manifestation of this disorder,
having different levels of disabilities and a wide range of skills and
symptoms. Importantly, ASD individuals are characterized not
only by the typically described social withdrawal and isolation
(Frith, 2003), but also by the presence of sensory abnormalities
(Posar and Visconti, 2018), difficulties in mentalizing processes
(Frith and Frith, 2003) and executive dysfunction (Hill, 2004).
Many treatments have been proposed, including behavioral,
educational, and medical interventions mainly directed toward
comorbid symptoms; however, there is no consensus regarding
which approach is the most effective. In the last years, NIBS
interventions have increasingly been considered in the treatment
of ASD.
rTMS
With respect to rTMS, 13 studies have been so far performed
with ASD children and adolescents and have mainly targeted the
dorsolateral prefrontal cortex (DLPFC) and the motor system.
DLPFC LF-rTMS
The first attempt to use rTMS with ASD patients was made by
Casanova, Sokhadze and colleagues (Sokhadze et al., 2009, 2010;
Casanova et al., 2012). They performed a series of studies that
were grounded on the notion of altered GABAergic signaling
pathways in ASD patients, which probably accounts for intra-
cortical inhibition dysfunction leading to an inhibitory/excitatory
(I/E) unbalance (Casanova et al., 2002, 2010; Fatemi et al.,
2014). This unbalance results, in turn, into abnormalities of
electroencephalography (EEG) gamma frequency oscillations,
which are considered as a neurophysiological biomarker
of autism (Brock et al., 2002). Furthermore, such an I/E
unbalance has been linked to abnormalities in the Event Related
Potentials (ERPs) components that reflect attention-orienting
and sustained-attention processes (Sokhadze et al., 2009). In
particular, by using a visual oddball paradigm, delayed latencies
of early (exogenous), and late (endogenous) ERP components
to non-target items have been found in ASD children as
compared to neuro-typical peers (Sokhadze et al., 2009). These
differences have been held to reflect a deficient ability in
recognizing the distinction between task-relevant and task-
irrelevant stimuli. Indeed, gamma oscillations and P300 increase
when the target is present as compared to when the target is
absent in non-impaired individuals. Conversely, ASD individuals
show comparable gamma oscillation and P300 responses to target
and non-target stimuli, because of higher responses to non-target
stimuli (Sokhadze et al., 2009, 2010). Furthermore, ASD children
differ from neurotypical peers in accuracy measures and post-
error reaction time (RT) adjustments, which is often seen as a
demonstration of an abnormal error monitoring and executive
control deficiency (Sokhadze et al., 2009, 2018).
These considerations and findings led to the proposal of
using LF-rTMS in order to alter cortical inhibition through
the activation of inhibitory GABAergic interneurons, resulting
in an improvement of I/E balance. Therefore, in a series of
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studies (Sokhadze et al., 2009, 2010, 2014a,b; Baruth et al.,
2010; Casanova et al., 2012; Sokhadze et al., 2018) the authors
addressed the effects of LF-rTMS (either 0.5Hz or 1Hz) on
EEG gamma frequency oscillations and on ERP components
during the execution of visual oddball tasks. Social and behavioral
functioning were assessed through parents’ reports using the
Aberrant Behavior Checklist (ABC), the Social Responsiveness
Scale (RBS), the Repetitive Behavior Scale-Revised (RBS-R), and
the Clinical Global Impression Scale (CGI).
In the first studies (Sokhadze et al., 2009, 2010), the difference
between the ASD EEG responses (gamma oscillations and
P300) to target and non-target stimuli increased after six
sessions of LF-rTMS (0.5Hz; 90% resting Motor Threshold,
rMT; 150 pulses per session) applied over the left-DLPFC.
In particular, the responses increased for target stimuli and
decreased for non-target stimuli, thus becoming more similar
to those observed in controls, and were associated to an
improvement of the behavioral performance of ASD adolescents
at the oddball task (Sokhadze et al., 2010). Furthermore, results
from clinical evaluations highlighted a reduction in repetitive-
ritualistic behaviors, mainly due to reduced obsessive-compulsive
behavior reported by caregivers. No changes were instead
observed in a waiting list (WTL) control group (Sokhadze et al.,
2009).
In two follow-up studies of the same group (Baruth et al.,
2010; Casanova et al., 2012), the authors replicated the results
measuring the EEG responses during an oddball task after a
longer rTMS treatment and in larger ASD sample (respectively,
25 and 45 patients) randomly assigned to either an rTMS
treatment or a WTL group. In particular, the 1Hz rTMS
treatment was administered once per week for 12 weeks. The
first 6 weekly sessions targeted the left-DLPFC (Sokhadze et al.,
2009), while the remaining 6 weekly sessions targeted the right-
DLPFC. As in the previous studies, the authors found, after the
rTMS intervention, but not in the WTL group, an improvement
in the discriminatory EEG responses to target and non-target
stimuli, as reflected by gamma power (Baruth et al., 2010) and
N200 amplitude (Casanova et al., 2012). These changes were
associated to an enhancement in selective attention and stimulus
discrimination as reflected by a reduction in error rate after
rTMS but not after WTL (Casanova et al., 2012). Furthermore,
participants were reported to have reduced repetitive and
restricted behavior, as measured by RBS, and reduced irritability,
as measured by ABC (Baruth et al., 2010; Casanova et al., 2012).
Notably, in Baruth et al. (2010), participants were also asked
to indicate any side-effects experienced after the stimulation.
The most commonly reported side effects (5 of 16 participants
in the active rTMS group) were an itching sensation around
the nose during the stimulation; one participant reported mild
and transient tension-type headache; no discomfort due to pulse
noise and no long-lasting side effects were reported. Then, the
effects of an 18-week-long, 1Hz rTMS treatment were tested
(Sokhadze et al., 2014a, 2018). In the first study (Sokhadze
et al., 2014a) the authors compared ASD participants receiving
the TMS treatment (N = 27) and ASD participants assigned
to a WTL group (N = 27). In the second study (Sokhadze
et al., 2018), they compared the effects of 6-, 12-, and 18 week
treatments in three different groups of high-functioning ASD
children and adolescents. In the 6 week group (N = 25) rTMS
was administered over the left-DLPFC; in the 12 week group
(N = 30) rTMS was delivered first over the left- and then over
the right-DLPFC; in the 18 week group (N = 31) additional
six treatments were done bilaterally over the left- and right-
DLPFC. 1-Hz rTMS was administered once a week. Basically,
the main results of both studies consisted in improved target
discrimination (shorter ERPs latency and smaller amplitude to
non-target items) after the end of the rTMS sessions in the active
rTMS group with respect to the WTL group (Sokhadze et al.,
2014a). The changes were greatest after the longest (18 weeks)
rTMS treatment (Sokhadze et al., 2018). Furthermore, both the
12 week (Sokhadze et al., 2018) and the 18 week rTMS groups
(Sokhadze et al., 2014a, 2018) showed a normalization in post-
error RT. Again, neuromodulation using rTMS, especially in
the 18 week group, resulted in significant changes in social and
behavioral functioning evaluation, scored by RBS, with a decrease
in ritualistic behavior and in stereotype behavior as compared to
the baseline level, and by a decrease in Irritability, Lethargy/Social
Withdrawal and Hyperactivity scores at the ABC.
Based on the results from their previous studies, which
showed an increase in gamma power after DLPFC-rTMS (Baruth
et al., 2010), in the study by Sokhadze et al. (2014b) the
same 18-week-long rTMS protocol over DLPFC was integrated
with prefrontal neurofeedback on gamma activity to upregulate
gamma oscillations. A group of 42 ASD patients were assigned to
an active (N = 20) or to a WTL group (N = 22). Immediately
after each rTMS session, participants were asked to perform a 20-
min session, during which visual and auditory feedback informed
them about the level of focused attention and gamma activity.
While replicating previous findings showing an improvement in
autistic symptoms, a behavioral improvement in the oddball task,
and a normalization in the ERP components, they also found
that the integrated rTMS and neurofeedback treatment enhanced
target discrimination and recognition and conflict resolution
during the processing of task-relevant and task-irrelevant stimuli.
Lastly, the effects of 0.5Hz DLPFC-rTMS were tested
on autonomic functions in a group of 18 high-functioning
(Casanova et al., 2014) and in a group of 33 high- and low-
functioning (Wang et al., 2016) ASD children and adolescents.
In ASD individuals an over-activation of the sympathetic
branch of the Autonomic Nervous System (ANS) and reduced
parasympathetic activity have been found (Ming et al., 2005),
and this dysfunction has been supposed to negatively affect social
behavior in ASD (Porges, 2001). Weak prefrontal inhibitory
control over the limbic system has been considered one of
the possible mechanisms explaining poor ANS control in ASD
(Loveland et al., 2008). By applying inhibitory rTMS over the
DLPFC, the authors aimed at reducing the high cortical E/I
ratio to improve sympatho-vagal balance in ASD. As autonomic
measures, heart rate variability and skin conductance level
were measured. Participants underwent the same DLPFC rTMS
treatments (as in Casanova et al., 2012) for 18 (Casanova et al.,
2014) or for 12 weeks (Wang et al., 2016). Social and behavioral
functioning was also measured and the same improvements were
found (see Casanova et al., 2012). Significant effects on both
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heart rate variability and skin conductance responses, indicating
an improvement in ANS control, were found in both studies,
suggesting that not only 18, but also 12 weekly sessions can have
beneficial effects in either high or low-functioning ASD. Notably,
no sham control condition or WTL group was used in these
studies. Considerably, despite the discreet amount of studies and
the positive effects they recorded in improving ASD symptoms,
it is not possible to ascertain how many patients were effectively
tested in these overlapping studies (i.e., whether and how many
patients were included in multiple studies) and, thus, how far
the observed results can be extended to the general population
of ASD individuals. Furthermore, the rationale for stimulating
first the left DLPFC (in the 6 week treatment), then also the right
(in the 12 week treatment) and then both areas bilaterally (in
the 18 week treatment) is unclear, likely based on the absence of
laterality specific effects in the hypothesized mechanism (i.e., I/E
unbalance). Crucially, laterality of stimulation (i.e., left, right, or
bilateral DLPFC) was confounded with the duration (i.e., 6, 12,
or 18 weeks), thus preventing disentangling whether the effects
were dose- or laterality-dependent.
Some of these findings have been recently replicated in
another study performed by a different research group using
a similar approach (Gómez et al., 2017). With respect to the
pioneering Casanova’s studies (Baruth et al., 2010; Casanova
et al., 2012), Gómez et al. (2017) used more stimuli per session
and more sessions to test the effects of inhibitory rTMS (and
tDCS) over the left- DLPFC on ASD symptoms. Namely, 24
children with ASD were enrolled in 20 daily sessions. Stimulation
was delivered by using 1-Hz rTMS in 11-year-old children and
cathodal tDCS for 10-year-old or younger children. In this last
case, tDCS was used to ensure effective focal stimulation over
the target areas also for young, less collaborative children. 1-Hz
rTMS was delivered over F3, through four trains of 375 pulses
(for a total of 1,500 pulses in each session), at an intensity of
90% of the rMT. Inhibitory (cathodal) tDCS was delivered over
the same F3 electrode position, by placing the anode over the
right arm, at an intensity of 1mA, for 20min. Clinical outcomes
were measured in all participants before and after one, 3 and 6
months from training completion, while a subset of participants
also underwent an EEG recording to compare, before and after
the treatments, functional connectivity at rest, and P300 during
a passive oddball task. After the intervention, 1-month later,
a significant decrease in the total score was observed in the
parents’ reports at the ADI-R, ABC, and Autism Treatment
Evaluation Checklist (ATEC) scales. Qualitative changes were
also described in the socialization and communication domains,
as measured with the GCIS. The effects were not different
for the TMS and tDCS interventions. Notably, the follow-up
showed that the significant change in the clinical scale scores
persisted up to 6 months after the completion of the treatment.
At the neurophysiological level, an increase in brain functional
connectivity was reported, with more prominent results in the
participants receiving rTMS and mainly linked to the gamma
band. ERP analyses showed a shortening of P300 latency after
treatment, without modulation of P300 amplitude. Notably,
a P300 with a delayed latency and a smaller amplitude has
been often reported in ASD patients and has been linked to
abnormal connectivity of the frontal lobes and to attention
deficits. Accordingly, the authors considered the shortening
of the P300 latency as linked to the increase of functional
brain connectivity, which could, in turn, explain the positive
clinical changes. However, this was an open-label study, with a
small number of participants receiving the active treatment (15
patients).
DLPFC iTBS
In a recent open-label study, Abujadi et al. (2017) tested the
effects of iTBS applied over the right-DLPFC on executive
function deficits and repetitive behaviors in 10 male children
and adolescents with ASD. The protocol aimed to promote long-
term potentiation (LPT)-like effects and to facilitate cortical
excitability by considering the role of this area in inhibitory
control and the right hemispheric impairment in LPT-like
plasticity in ASD. Fifteen sessions of 300-s iTBS were performed
5 days a week with a stimulation intensity of 100% rMT. Baseline
and post treatment measures included the parent report score at
the RBS-R and at the Yale- Brown Obsessive Compulsive Scale,
the perseverative errors on the Wisconsin Card Sorting Test
(WCST) and total time for the Stroop test. These measures were
taken at baseline, on the last day of iTBS treatment and at a
3 months follow-up visit. The authors found an improvement
from baseline to post-treatment in restricted and repetitive
behaviors, and compulsions. Neurocognitive functions also
improved, since a decrease in perseverative errors at the WCST
and in time for completing the Stroop test was observed. The
authors reported that participants tolerated the iTBS protocol
with no significant side effects and no seizures; furthermore,
all participants completed the treatment, even if only five
participants were available for the follow-up measurements;
the follow-up suggested, however, that the improvements were
maintained. Importantly, this pilot study does not allow for
a proper assessment of the efficacy of the treatments, since
no control conditions were included. Future studies are thus
required (Ameis et al., 2017).
Motor HF-rTMS
A study by Enticott et al. (2012) focused on motor dysfunction in
ASD, by considering in particular the alteration in EEG activity
preceding and immediately following voluntary motor actions
(i.e., movement-related cortical potentials, MRCPs). Typically,
1–2 s before the movement, EEG activity is characterized by an
early negative component, which originates in the supplementary
motor area (SMA) and reflects preparatory processes, and by
a later bigger negative component, which originates in the
contralateral M1 and is associated to the specific implementation
of the movement. The early preparatory component has been
found to be abnormal in patients with ASD, who show reduced
component gradient and peak amplitude (Rinehart et al., 2006).
This study was aimed at testing the effects of LF-rTMS over
the SMA on the motor function of 11 adolescents and adults
with ASD. The rTMS treatments included three separate sessions
(1 week apart) during which, in counterbalanced order across
participants, 1-Hz rTMS was delivered at 100% rMT for 15min
(900 pulses) over the left-M1, the SMA, and in a Sham condition
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(by tilting the coil at 45◦ away from the scalp). Before and
after rTMS, MRCPs were recorded during the execution of
an externally-cued sequential button-pressing task. Behavioral
performance in the motor task and cortico-spinal excitability
were also recorded. The authors found that SMA-rTMS increased
the gradient of the early MCRP component, while left-M1-rTMS
increased the gradient of the late component, thus producing a
change toward normalization of the MCRP components that are
altered in autism. At the same time, however, a reduction in the
early component gradient was seen after sham, perhaps reflecting
practice effects in task execution. No other differences were found
depending on stimulation, neither on the behavioral performance
nor in cortico-spinal excitability, thus suggesting the need of
further investigation and optimization of the protocol.
Interestingly, with respect to visuo-motor abilities, in a series
of preliminary studies (Panerai et al., 2014), the effects of rTMS
protocols in performing eye-hand integration tasks were tested in
different samples of low-functioning ASD children with severe-to
profound mental disability. Firstly, the authors tested the effects
of HF-rTMS (8Hz), LF-rTMS (1Hz), and sham-rTMS delivered
over the left- and the right-premotor cortex (PMC) of nine male
ASD adolescents in performing an eye-hand coordination task.
HF-, LF-, and sham rTMS were delivered in three separate daily
sessions, with a 2 week interval between sessions. Since the results
from this first preliminary study showed that HF-rTMS over the
left-PMC was the most effective in inducing an improvement in
the eye-hand coordination task, a second study aimed to confirm
the effect of repeated rTMS sessions in a total of 17 ASD children,
assigned to a group receiving: (i) HF-rTMS (N = 6); (ii) LF-rTMS
(N = 6); or (iii) sham rTMS (N = 5). The stimulations were
delivered over the left-PMC for a period of 10 days over 2 weeks.
Eye-hand integration abilities and fine motor performance were
tested before the first and after the last stimulation session. Again,
results seemed to suggest a greater pre-to-post increase of eye-
hand integration performance in the HF-rTMS than in the LF-
and Sham-rTMS groups. Unfortunately, the difference in time for
the HF-rTMS group did not survive after multiple comparisons
correction. Thus, limited sample size and uncorrected findings
urge caution when interpreting the results. Nevertheless, HF-
rTMS seemed to improve eye-hand integration abilities also in
a third study, where it was also shown, albeit again in a very
limited sample size (N = 4), that the improvements seemed to
last for up to 1 h after the end of the stimulation. Finally, a
fourth study compared the long-lasting effects of the same rTMS
treatment (N = 4), of an eye-hand integration training (N =
5) and those of a treatment combining HF-rTMS followed by
the eye-hand integration training (N = 4). During the eye-hand
integration training, children were asked to accomplish several
eye-hand integration activities (e.g., button and unbutton) for
15min. The authors found that performance was better in
the combined HF-rTMS and eye-hand integration treatment,
and the improvements maintained up to 1 h after the end
of the stimulation. These preliminary findings highlighted the
possibility to use rTMS for the rehabilitation of motor functions
in children with ASD and pointed to the opportunity to combine
brain stimulation and cognitive training in order to boost the
effects of functional interventions. Crucially, prudence is needed
taking into account the sample size and statistical limitations of
these studies.
tDCS
To date, only four studies (in addition to study by Gómez et al.,
2017; see above) have applied tDCS in children or adolescent with
ASD: 1 open-label, non-controlled study (Schneider and Hopp,
2011) addressing language impairments, two randomized sham-
controlled studies by Amatachaya et al. (2014, 2015) addressing
ASD clinical symptoms and psychosocial functioning, and a case
report (Costanzo et al., 2015) addressing drug-resistant catatonia
in a patient with ASD.
Left-DLPFC Anodal tDCS
An open label study by Schneider and Hopp (2011) investigated
the effect of tDCS on syntax acquisition in a sample
of 10 children/adolescents with ASD and severe language
impairments. Using a modified version of the Bilingual Aphasia
Test, vocabulary, and syntax comprehension were assessed before
and after exposing participants to anodal tDCS over the left-
DLPFC. The intervention was based on the evidence of a
hypo-activation of the left hemisphere toward a rightward
lateralization in ASD (Kleinhans et al., 2008; Cardinale et al.,
2013). Anodal tDCS was expected to increase the activation of
the left hemisphere, thus reducing the left hypoactivation, and
modulating autistic behaviors. Participants were administered
one 30-min session of anodal tDCS (2mA, 0.08 mA/cm2)
to the left-DLPFC by placing a 5 × 5 cm electrode over F3
(according to the 10–20 system). The cathode was placed over
the right supraorbital region. Before and after tDCS, they
were administered three tests. Firstly, a vocabulary testing was
performed, during which children were instructed to touch
a stimulus upon verbal request. The vocabulary testing was
followed by a syntax training, in which participants were asked
to select the pictures corresponding to a series of verbally
presented scaffolding sentences, which approximated the syntax
of the sentences used in the following syntax comprehension
test. In this last task, children were asked to select a picture
corresponding to a sentence presented in its canonical subject-
verb-object sequence. tDCS was well-tolerated and no side
effects were reported. After tDCS, an improvement in syntax
acquisition and vocabulary scores occurred, thus suggesting
possible therapeutic benefits from tDCS on language abilities
in ASD. However, the design of this open-label study, which
did not include a sham, control condition, did not allow ruling
out the possibility of placebo effects. Thus, the same left-
DLPFC area was targeted with anodal tDCS in a randomized
double-blind controlled placebo crossover trial with 20 ASD
children (Amatachaya et al., 2014). After the baseline evaluation,
anodal, or sham tDCS stimulation (counterbalancing between
participants) was delivered for 5 consecutive days, and it was
followed by 1 week of assessment. After 4 weeks of washout, the
same cycle was repeated with the other stimulation condition.
During the treatment, participants were asked to continue their
routine medications. TDCS was delivered at an intensity of 1mA,
for 20min in each session, through 35 cm2 sponge electrodes
placed over F3 (anodal) and over the contralateral shoulder
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(cathodal). Sham stimulation was achieved by using the same
electrode placement, but switching off the stimulation after 30 s.
The main assessment measures, taken before and after the active
and sham tDCS treatments, were the CARS, to assess autism
severity, the ATEC, to evaluate the effectiveness of the treatments
through caregivers’ reports, and the CGAS, to globally assess
child’s psychosocial functioning. Parents were asked to report
any adverse events every day after the treatment. Generally, a
significant amelioration at CARS, ATEC, and CGAS were found
after anodal stimulation with respect to the sham condition, with
the exception of the language domain at the ATEC. No adverse
effects were reported. Notably, all participants completed the
study, suggesting that the treatment was well tolerated.
In a follow-up study, Amatachaya et al. (2015) sought to
replicate and extend these findings (N = 20) by examining the
effects of anodal tDCS on ASD behavior and by assessing whether
such improvements correlated with functional changes in brain
connectivity. In particular, starting from the EEG evidence
showing reduced power in middle range (alpha) frequencies in
ASD, they hypothesized that the behavioral effects of prefrontal
tDCS weremediated by increases in alpha frequency and synaptic
connectivity. EEG was recorded 10 times (before, immediately
after, at 24, 48, and 72 h after active and sham tDCS). According
to the hypothesis, the results showed, after anodal- but not sham-
tDCS, a significant improvement of the ATEC social scale and
an increase of the EEG peak alpha frequency recorded from
the electrodes close to the stimulation site. Importantly, the
greater the increase of synaptic connectivity, as indexed by the
increase in peak alpha frequency, the greater the improvements
in psychosocial functioning, as measured with the ATEC. Again,
no serious adverse effects were found, with the exception of an
erythematous rash in three participants, which cleared within
10min after the stimulation. Overall, the results from these
studies highlight the feasibility of DLPFC tDCS to improve
autistic behavior, even if further studies with larger and more
representative ASD children are needed.
Bilateral DLPFC tDCS
In a case report, Costanzo et al. (2015) described the effect
of tDCS over the DLPFC in an adolescent girl (14 years
old) with ASD and drug-resistant catatonia. Catatonia is a
syndrome mainly featured by the presence of catalepsy, waxy
flexibility, stupor, agitation, mutism, negativism, posturing,
mannerism, stereotypies, grimacing, echolalia, echopraxia
(American Psychiatric Association, 2013). Catatonia is often a
comorbid syndrome of ASD, with the two conditions sharing
abnormalities in prefrontal and parietal activation and in their
functional connectivity (Northoff, 2002; Richter et al., 2010; Just
et al., 2012). Notably, current treatments for catatonia include
pharmacotherapy with benzodiazepines, and electroconvulsive
treatment for drug resistant patients. However, use of rTMS
and tDCS has been proposed in adults (Kate et al., 2011;
Shiozawa et al., 2013) and in adolescents (Costanzo et al., 2015)
as a safer and less invasive alternative to electroconvulsive
treatment. The patient described by Costanzo et al. (2015)
was resistant to many different pharmacological treatments,
including the administration of benzodiazepines, antipsychotics,
antidepressants, anticonvulsants, and even a worsening in
her conditions had been observed before deciding to assign
her to a tDCS treatment. 1mA tDCS was applied over the
right-DLPFC (cathodal) and the left-DLFPC (anodal) for
20min, through 5 × 5 cm scalp electrodes. The stimulation was
applied in 28 consecutive daily sessions, while keeping constant
other medications. At the end of the treatment, catatonic
symptoms, as measured with the Kanner Catatonia Rating
Scale showed a 30% decrease, and the effects were stable at a
1-month follow-up evaluation. Although these findings should
be interpreted keeping in mind the limitations of a single case
report design, further studies are warranted to better determine
the effectiveness of tDCS on catatonic symptoms.
To sum up, in most of the studies with ASD, TMS, or tDCS
were delivered over the DLPFC, but the same area was targeted
with either inhibitory and facilitatory protocols. To the best
of our understanding, inhibitory protocols over DLPFC have
been applied to reduce I/E unbalance, considering GABAergic
signaling reduction in either the left- or right-DLPFC. In this
line, the rationale for and the effects of switching from left
to right and bilateral stimulation are unclear, since no direct
comparison has been tested to dissociate laterality effects in the
inhibition of the DLPFC. Conversely, facilitation in the right-
DLPFC has been induced to boost LTP-like plasticity and to
increase the involvement of this are in inhibitory control. Lastly,
the studies assessing the effect of facilitatory tDCS over the left-
DLPFC sought to improve the symptomatology by decreasing the
rightward lateralization in ASD. The choice of the E/I protocol
and/or target site seems driven by the targeted function within
the wide autistic spectrum. Thus, a deeper consideration of the
specific clinical features of the target population and of the
rationale for a specific neurofunctional target is recommended.
ADHD
ADHD is one of the most impairing and prevalent childhood
disorders with a worldwide prevalence of 7%, as estimated in
2015 (Thomas et al., 2015). It is featured by the presence of a
persistent pattern of inattention and/or hyperactivity-impulsivity
that profoundly affects or reduces the quality of social, academic,
and occupational achievements. These symptoms are present
prior to the age of 12, but they often persist into adulthood.
Influential models of ADHD mainly focus on a deficit in
inhibitory control that leads to executive dysfunctions, associated
to neural alteration in the prefrontal areas, the striatum, and the
cerebellum (Rubia, 2018).
Medication management has long been the standard
treatment, and it has been mainly based on the administration of
stimulant (methylphenidate) and non-stimulant norepinephrine
reuptake inhibitor (atomoxetine). Both agents increase dopamine
(DA) and norepinephrine (NE) in the prefrontal cortex via
different mechanisms (Bymaster et al., 2002), but they produce
similar therapeutic effects. However, they can be problematic for
some individuals whose comorbid conditions can be worsened by
the stimulant treatment. At the same time, a recent meta-analysis
showed that cognitive trainings alone have limited clinical
efficacy and limited transfer effects beyond the specific targeted
neuropsychological processes (Cortese et al., 2015). In this vein,
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non-medication treatment alternatives through NIBS would be
helpful. Important insights for the use of NIBS in treating ADHD
symptoms come from studies showing that cortical excitability
in children with ADHD is abnormal, owing to a reduction of
motor inhibition (Buchmann et al., 2003), and from studies
demonstrating that the two classes of drugs for ADHD act by
altering cortical excitability (Gilbert et al., 2006). Thus, in light of
the possibility to affect non-invasively cortical excitability, NIBS
can be proposed as an effective alternative to the use of these
drugs. Notably, it has been proposed that the behavioral deficits
in ADHD can be related either to faulty inhibitory processes,
resulting into a failure in executive control, impulsive behavior,
and hyperactivity (inhibition-based model), or to impaired
motivational and reward processing [motivational-dysfunction
model (Cepeda et al., 2000; Sonuga-Barke, 2005)]. According to
these models, the DLPFC should be the primary region involved
in inhibitory deficits, whereas the orbitofrontal cortex (OFC)
should be more closely implicated in motivational dysfunction.
These areas have been the target of most attempts to use rTMS o
tDCS in ADHD.
rTMS
To date, three studies have applied rTMS in children and
adolescents with ADHD, targeting either motor or DLPFC sites:
two randomized sham-controlled studies and one open-label
tolerability and safety study.
Motor Cortex LF-rTMS
In a first randomized, sham-controlled study, Helfrich et al.
(2012) tested the effects of inhibitory (1-Hz) rTMS in modifying
the I/E unbalance in the motor system of patients with
ADHD. Their investigation aimed to monitor, online, the
effects of LF-rTMS in children with ADHD (N = 25) by
using neurophysiological measures, namely TMS Evoked EEG
Potentials (TEPs) and motor evoked potentials (MEPs). In
particular, they expected an increase of the N100, which is
known to reflect motor cortical inhibition and to be the most
pronounced TEP deflection in children (Bender et al., 2005).
TEPs and MEPs in response to single-pulse TMS (110% rMT)
were measured before and after active 1-Hz rTMS (900 pulses,
80% rMT) or sham stimulation (achieved through a deactivated
coil) over the left M1. The two stimulation conditions were
delivered in counterbalanced order 30min apart. The authors
reported that rTMS was well-tolerated, with only three children
reporting mild transient headache and no signs of epileptic
activity from EEG recording, before, during, or after rTMS.
Analyses on TEPs revealed an overall decrease of N100 amplitude
during and after 1-Hz rTMS, as compared to both baseline
recording and sham stimulation. Surprisingly, rTMS did not
affect MEP amplitudes, even if, for both active and sham
stimulations, less negative N100 were associated with smaller
MEP amplitudes. However, since the authors found a decrease,
rather than the expected increase in N100 after inhibitory LF-
rTMS (Casula et al., 2014), these results did not support the
use of rTMS to increase intracortical inhibition in ADHD.
Further investigations of the effect of LF-rTMS are thus definitely
necessary to assess whether or not it can be an appropriate
therapeutic tool in ADHD.
DLPFC HF-rTMS
In a randomized, sham-controlled, crossover study by Weaver
et al. (2012), nine adolescents and young adults were tested. The
design included two treatment phases, each lasting 2 weeks, with
1 week interval of no treatment between phases. Each participant
received either active or sham HF-rTMS over the right-DLPFC,
in a counterbalanced order. The sham stimulation was delivered
by tilting the coil at 90 degrees. 10-Hz rTMS was delivered
at 100% of the rMT (2,000 pulses per session, 5 sessions per
week). Assessment measures for the clinical evaluation included
the CGI-I and the ADHD-IV scale, taken at baseline, at the
midpoint and at the end of the study. The authors reported
that rTMS was well-tolerated, with no serious adverse effects
recorded and without drop-outs during the treatment. Only mild
headache and scalp discomfort were reported. Even if significant
improvements in CGI-I and ADHD-IV were found, comparable
changes were observed after both active and sham rTMS. Thus,
for both measures, placebo or time effects could not be excluded.
DLPFC LF-rTMS
Gómez et al. (2014) investigated the tolerability and safety of
LF-rTMS in 10 children with ADHD, in an open label trial.
All children were classified as non-responders to conventional
treatment. The treatment consisted in five consecutive daily
sessions of 1-Hz rTMS (90% rMT) over the left-DLPFC, with a
total of 1,500 stimuli per session. Parents and teachers were asked
to complete the Symptoms Check List (SCL) for ADHD before
and 1 week after completing the rTMS sessions. Authors reported
that all children well-tolerated and completed the treatment,
with 70% of participants complaining only slight headache or
local discomfort, 20% neck pain, and one patient reporting
brief dizziness in two sessions. Parents’ and teachers’ reports
revealed a significant improvement in children’s behavior at
school (inattentiveness) and home (hyperactivity/impulsivity).
However, the lack of a control, sham condition, the small sample
size, and the open label design of this study did not allow drawing
any firm conclusions about this efficacy outcome.
In conclusion, the only study showing a therapeutic effect of
rTMS on ADHD symptoms in children (Weaver et al., 2012)
did not show superior effects of rTMS over sham rTMS. Then,
results from the Helfrich et al. (2012)’s study suggested a decrease
in intracortical inhibition, while the design of the Gómez et al.
(2017)’s study, missing a control condition, did not allow testing
its clinical efficacy. Future investigations on the efficacy of either
LF- or HF-rTMS on ADHD are thus required.
tDCS
More promising findings come from the studies investigating the
effect of tDCS in ADHD. To date, eight studies have applied
tDCS in children and adolescents with ADHD: five randomized,
double-blinded, sham-controlled trials (Prehn-Kristensen et al.,
2014; Munz et al., 2015; Nejati et al., 2017; Soff et al., 2017;
Sotnikova et al., 2017), two randomized, single-blinded, sham-
controlled trials (Soltaninejad et al., 2015; Breitling et al., 2016),
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and one non-controlled, auto-matched open trial (Bandeira et al.,
2016). The studies have mainly addressed memory consolidation,
working memory and inhibitory control by targeting the DLPFC
with different tDCS protocols.
DLPFC Slow-Oscillating tDCS
A first series of studies used slow oscillating tDCS (toDCS)
to interact with physiologically slow oscillatory activity during
sleep. A double-blinded, sham-controlled crossover study with
toDCS (Prehn-Kristensen et al., 2014) was mainly focused on
deficits in declarative memory. Declarative memory is thought to
benefit from slow-wave sleep, characterized by slow oscillations
that originate from frontal brain areas. In ADHD children,
the alteration in frontal brain activity and, thus, in slow-wave
oscillations (Ringli et al., 2013) is thought to lead to impaired
memory consolidation during sleep. Thus, 0.75Hz toDCS was
used to externally trigger an increase of slow oscillations during
early slow-wave sleep in 12 ADHD male children. Twelve
healthy boys were recruited as control group, but they were
not stimulated for ethical concerns. Anodal toDCS was applied,
with two synchronized stimulators, over two electrodes (inner
diameter: 0.503 cm2) placed bilaterally at frontolateral locations
(F3 and F4), with the ipsilateral reference electrodes placed at the
right mastoid. For each anodal electrode, stimulation intensity
ranged from 0 to 250 µA. Sinusoidal stimulation was started
4min after patients had entered non-REM sleep stage 2 for the
first time and it was applied in a series of five 5-min intervals
separated by 1-min intervals without stimulation. Each ADHD
participant received either active or sham stimulation, with a 1
week break. Declarativememory was assessed in both ADHD and
control groups by a computerized memory task, comprising an
encoding procedure before night-sleep and at awakening in the
morning. Results showed an increase in slow-oscillation activity
after active toDCSwith respect to sham.More interestingly, while
the memory loss of ADHD children at retrieval after sham was
higher than that of the control group, the difference vanished
after active toDCS.
A similar study design was then used in a second study
published by Munz et al. (2015) to assess whether augmenting
slow-wave power during non-REM sleepmay improve behavioral
inhibition. Fourteen children and adolescents with ADHD were
included in the study. Behavioral inhibition was tested through
a Go/No-go task, asking participants to press a button when a
sad ghost appeared, to refrain from responding when a smiling
ghost was presented, and to ignore a visual distractor presented
in 50% of the trials. The same procedure and toDCS parameters
of the previous study (Prehn-Kristensen et al., 2014) were used.
Faster RT and decreased intra-subject variability were observed,
suggesting a positive effect on executive functions related to
motor inhibition. Overall, findings from these studies suggested
that toDCS may be considered as a useful tool to increase
slow oscillatory power during sleep in DLPFC, thus improving
declarative memory and executive functions in ADHD.
Left-DLPFC tDCS
In a pilot study, Bandeira et al. (2016) explored the effects of
anodal tDCS over the left-DLPFC on a sample of nine children
and adolescents. The anodal electrode was placed over F3 and
the cathodal over the right supraorbital area. Stimulation was
delivered in five consecutive daily sessions. During each 30min
session, stimulation was set at an intensity of 2mA (except in
the first and in the last minute of stimulation, when it was
decreased to 1mA). Importantly, in order to trigger the activation
of the DLPFC, participants were engaged in a card matching
game, in which they were asked to match pictures and to create
associations between pictures. The effects of anodal DLPFC-
tDCS were assessed on several executive functions, including
working memory and attention, measured through the Digit
Span subtest of the WISC-III, inhibitory control, measured by
a subtest of the NEPSY-II, visual working memory and visual
attention, measured through the Corsi test, and visual attention,
measured by a Visual Attention Task. These outcome measures
were taken before the first and after the last tDCS session.
Furthermore, at the end of the last session, the Patient Global
Impression of Improvement was administered to participants’
parents, to assess evolution across the treatment. At the end of
each tDCS session, participants were asked about any adverse
effects occurred during the procedure or after the intervention.
Mild and moderate intensity of headache, neck pain, itching,
burning, and tingling sensations in the anode positioning site,
local redness, and sleepiness were often acknowledged.Moreover,
a mild sense of shock was also referred. The higher intensity of
stimulation, with respect to the other studies, which have mainly
using 1mA, can account for this discomfort. An enhancement
in visual attention and in inhibitory control after tDCS was
observed. Overall, improvements were also found in parents’
reports, with only one case pointing toward a worsening in
child’s behavior (in this last case, oppositional defiant disorder
was a comorbid condition). Unfortunately, the lack of a control
sham condition did not allow testing the specific efficacy
of the treatment or to exclude practice effects. Furthermore,
participants and parents were not blinded about the stimulation
conditions, thus the occurrence of placebo effects could not be
excluded.
Conversely, a randomized, double-blinded, sham controlled
crossover design was used by Soff et al. (2017) to assess
the effects of anodal vs. sham tDCS over the left DLPFC
on working memory and on the clinical course of ADHD.
The rationale under the use of anodal tDCS over the left-
DLPFC to improve working memory resided on the observations
of diminished activation of this area in ADHD, and in the
possibility to improve the working memory performance of
healthy participants with anodal stimulation of the left-DLFPC.
Fifteen adolescents with ADHD were included. Each participant
received, in a counterbalanced order, either anodal or sham
stimulation, which were delivered in 5 consecutive days, with
a 2 week washout interval between the two treatment periods.
1mA tDCS was delivered for 20min (anodal) or 21 s (sham) with
the anodal electrode over F3 and the cathodal electrode over the
vertex Cz. Stimulation was delivered online during performance
of an N-back working memory paradigm, combining measures
of task performance with recording of motor activity to assess
the core symptoms of ADHD, namely inattention, hyperactivity,
and impulsivity. Furthermore, working memory performance
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and parents’ reports of ADHD symptom severity were also
assessed at baseline, at the fifth day of stimulation, and
1 week after the end of the stimulation. All participants
completed the study and the protocol was well-tolerated. Mild
tingling and itching sensations under the electrodes were the
most commonly reported adverse effects; only one participant
complained headache. Anodal tDCS, as compared to sham
stimulation, led to an improvement of ADHD symptoms. In
particular, as compared to the baseline measurements, a long-
lasting decrease in inattention and hyperactivity was found 7
days after the end of the treatment, without significant effects
on impulsivity. Interestingly, in a further study (Sotnikova et al.,
2017), the authors also reported the results of the fMRI recording
conducted at the first session of anodal or sham DLPFC-tDCS
during performance of the N-back task. With respect to sham
stimulation, anodal tDCS induced greater activation not only in
the area under the electrode, namely the left-DLPFC, but also in
the ipsilateral PMC, SMA, and precuneus, thus suggesting that
DLPFC- tDCS is likely to influence the whole neural network
associated with working memory performance. However, the
limited sample size of these studies allows providing only a proof
of principle for the application of tDCS in ADHD, while future
studies are needed.
Right-PFC tDCS
Considering the role of the right-PFC in inhibitory control,
Breitling et al. (2016) investigated the effect of anodal tDCS
over the ventrolateral prefrontal cortex (VLPFC) to improve
interference control in ADHD. Twenty-one male adolescents
with ADHD and 21 age-matched male adolescents without
ADHD were included in this randomized, sham-controlled
cross-over study. Each participant received three sessions of
anodal, cathodal, or sham tDCS, separated by at least 1 week,
while completing a flanker task. Order between stimulations was
counterbalances across participants, who were blinded to the
stimulation condition. 1-mA tDCS was delivered by placing the
anodal or the cathodal electrodes (7 × 5 cm, current density:
0.029 mA/cm2) on F8, and the reference electrode posteriorly
to the left mastoid. Active stimulation was delivered for 20min
(with a 30 s ramp up and down), while in the sham condition
the stimulation was on only during the 30 s ramp-up and ramp-
down phases. Participants were asked to rate on a 5-point Likert
scale the intensity of skin sensations during tDCS and their
ability to concentrate. The same effects for anodal, cathodal, or
sham stimulation on the ability to concentrate were reported,
while more intense burning sensation for cathodal than sham
stimulation emerged. Concerning participants’ performance in
the main task, differences between ADHD adolescents and
controls were only found in those participants who started
with the sham session, pointing to learning effects in the
other sessions. Thus, the analyses were limited to comparisons
of the three stimulation conditions administered in the first
session, reducing sample size to seven participants per group.
Interestingly, while no differences were present between the
control participants who received anodal or sham stimulation
in the first session, the ADHD patients who received anodal
stimulation had lower commission error rates with respect to
patients receiving sham. Unfortunately, the small sample size of
the final analyses and the lack of clinical outcome measures limit
the conclusions that could be drawn from the study.
Bilateral PFC tDCS
Further studies have confirmed the possibility to enhance
inhibitory control by altering the activity of the PFC through
a combination of inhibitory stimulation of the left hemisphere
and excitatory stimulation of the right hemisphere in ADHD
(Soltaninejad et al., 2015; Nejati et al., 2017). Soltaninejad
et al. (2015) aimed to decrease the activity of the left-
DLPFC to remediate inhibitory control through disinhibition
of the homologous contralateral area, the right DLPFC, whose
activation is suggested to be crucial in inhibitory control (Depue
et al., 2010). Twenty adolescent students scoring 1.5 SD higher
than the mean of a population of peers at the CAARS-S were
enrolled. Two tasks measuring inhibitory control were chosen,
the Stroop task and a Go/No go task, providing a measure of
interference inhibition and prepotent inhibition, respectively.
Each participant underwent, with a counterbalanced order, three
stimulation sessions of 1.5mA anodal, cathodal, and sham tDCS,
each lasting 15min, with an inter-session break of 72 h. Eight
minutes after the beginning of the stimulation, the Go/No-go
and the Stroop test were performed for the following 7min.
The anodal or the cathodal electrode was placed over the
left-DLPF (F3), while the reference electrode was placed over
the right supraorbital area (Fp2). In the sham condition, the
current was delivered for 15 s and then turned off. While
performance in the Stroop test and, thus, in interference control
was not affected, performance in the Go/No-go task and, thus, in
inhibitory control of prepotent response, changed depending on
the stimulation. Interestingly, as compared to sham stimulation,
accuracy in the No-go trials increased after cathodal tDCS,
while accuracy in the Go-trials increased after anodal tDCS. The
authors argued that inhibitory stimulation of the left-DLPFC
with cathodal tDCS might have disengaged interhemispheric
inhibition, thus increasing the activation of the right-DLPFC,
which is necessary for inhibitory control of prepotent responses.
At the same time, it is important to acknowledge that this
facilitatory effect on response inhibition could be linked to the
anodal stimulation of the right-OFC, which underlies Fp2, and
might also have affected the activity of the right-DLPFC (Nejati
et al., 2017). Indeed, the studies reported above did not clarify the
way in which different PFC regions may contribute to different
executive functions in ADHD.
A recent study by Nejati et al. (2017) aimed to investigate
the effects of tDCS of DLPFC and OFC on a wide range
of executive function domains, including inhibitory control
of prepotent response (Go/No-go), inhibitory control of
interference (Stroop), working memory (N-back), and cognitive
flexibility/task switching (WCST). In this randomized, double-
blinded, sham-controlled crossover study, 25 children were
assigned to one of two different experiments. In Exp.1 (N
= 15), the effects of anodal stimulation of the DLPFC (F3)
combined with cathodal stimulation of the right-DLPFC (F4)
were compared with the effect of a sham stimulation of the
same regions. In Exp.2 (N = 10), three stimulation modalities
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were compared: (i) anodal stimulation of the left-DLPFC (F3)
combined with cathodal stimulation over the OFC (Fp2); (ii)
cathodal stimulation at F3 combined with the anodal stimulation
of Fp2; (iii) sham stimulation of the same regions. 1mA
constant current (with a 30 s ramp-up and ramp-down phase)
was delivered for 15min in the active conditions, while it
was ramped up for only 30 sec in the sham condition. A
washout period of 72 h between the tDCS sessions was included.
No adverse effects were reported, except for mild itching or
tingling sensations under the electrodes. Exp.1 showed that
F3-anodal/F4 cathodal stimulation, as compared to sham, did
not induce any significant change in inhibitory control or
in cognitive flexibility/task switching; however, it improved
interference control, by increasing accuracy and decreasing RT
in the Stroop task, and working memory, by reducing RT, but
not accuracy in the N-back task. Exp 2 showed significant
changes in inhibitory control, cognitive flexibility, and working
memory, depending on the electro montage. In particular,
as compared to sham, F3 cathodal/Fp2 anodal stimulation
improved prepotent response inhibition, in terms of accuracy
in the Go/No-Go task. Conversely, F3 anodal/Fp2 cathodal
stimulation improved cognitive flexibility/task switching, as
reflected by less perseverative errors and more completed
categories at the WCSR, and working memory abilities, with
increased accuracy and increased RT in the N-back task. Even
if this study did not provide any insight about the effectiveness of
tDCS in improving ADHD symptoms at clinical levels, findings
from this theory-driven study are very relevant in highlighting
the site- and polarity-specific effects that can be achieved by
targeting different PFC areas in both hemispheres to improve
executive functions in adolescents with ADHD. Indeed, tDCS
over different prefrontal regions may be useful and necessary to
improve the range of cognitive functions that are impaired in
ADHD.
TS and tic Disorders
TS is a neurodevelopmental disorder characterized by vocal
and motor tics that occur consistently for at least 1 year.
The symptoms often last for years and have dramatic effects
on physiological and physical development, being associated
with aggression, impulsivity, mood and anxiety disorders, poor
social skills, low self-esteem, family conflicts, and obsessive-
compulsive behaviors. To increase tic control, psychological
counseling, and alpha-2 adrenergic agnostic and antipsychotics
drugs are commonly prescribed. However, many children with
TS do not tolerate/respond to drug therapy, impelling to
identify new models of intervention (Du et al., 2010). Even
if the etiology of this syndrome is still unclear, neuroimaging
evidence supports the involvement of brain network including
the motor areas, basal ganglia, and the reticular activating system
(Gerard and Peterson, 2003). Along the cortical surface that
is readily accessible to rTMS, the SMA has been considered
a potential target area for focal non-invasive stimulation in
TS in vein of its extensive connections with cortical and
subcortical motor areas. Moreover, abnormal cortical-subcortical
inhibition and hyperexcitability of the motor cortex has been
reported in TS (Grados et al., 2018). Furthermore, increased
bilateral activation of SMA has been associated with voluntary
tic generation (Bohlhalter et al., 2006). Thus, reducing excessive
motor activation by inhibitory SMA stimulation has been
proposed to be effective in treating TS (Munchau et al., 2002;
Kwon et al., 2011; Le et al., 2013; Bloch et al., 2014). With
respect to pediatric and adolescent patients, only three studies
explored the effects of NIBS on TS symptoms: two pilot, open-
label studies using 1Hz LF-rTMS (Kwon et al., 2011; Le et al.,
2013), and a double-blind study using a cTBS protocol (Wu et al.,
2014). Notably, despite many possible advantages linked to the
use of tDCS to reduce cortico-spinal excitability and increase
intracortical inhibition in TS, no tDCS studies on this topic were
found.
rTMS
SMA LF-rTMS
In a pilot study by Kwon et al. (2011), 10 right-handed
male children and adolescents with moderate-to-severe tics
were enrolled, while children with conduct disorder, pervasive
development disorder, mental retardation (IQ <70) and
neurological disorders, including head trauma, strokes, or
epilepsy, were excluded. The protocol included 10 stimulation
days, interspersed across 12 weeks, during which rTMS was
delivered with a frequency of 1Hz in four trains, each lasting
5min, with an inter-train interval of 2min (for a total of 1,200
stimuli/day). Importantly, rMT was daily taken from the primary
motor cortices and the stimulation was adjusted at an intensity
of 100% of the lowest (i.e., left or right) daily rMT. rTMS
stimulation was delivered over the SMA, which was defined
by considering the 15% of the distance between the inion and
nasion anterior to Cz on the sagittal midline. Rating measures
for tics included the Yale Global Tic Severity Scale (YGTSS),
which scores the severity of motor and vocal tics, and the
CGI, assessing the adverse impact of tic behaviors on patients’
life. Additionally, the Korean versions of the Conner’s ADHD
scale, DuPaul ADHD Scale, Children Depression Inventory, and
Spieberger State/Trait Anxiety Scale as well as a computerized
ADHD Diagnostic System were administered. These measures
were taken before starting the intervention (baseline) and at the
end of the daily sessions delivered 1 week, 2 weeks, and 12 weeks
after the beginning of the intervention. The authors found a
significant increase of rMT, for both the right and left motor
hotspot, while the total YGTSS score decreased in the first 2
weeks of treatment. No other significant differences were found.
The authors reported that the rTMS sessions were well-tolerated,
with only one participant complaining a slight scalp pain; all
participants completed the study.
Based on these results, in a second study by Le et al.
(2013), 25 children and adolescents with TS underwent a similar
rTMS protocol, but lasting 20 sessions for 4 weeks. Assessment
measures were taken before and after each daily treatment and
at 2 weeks, 4 weeks, 3 months, and 6 months after rTMS.
Thus, as compared to the Kwon et al. (2011)’s study, this study
allowed detecting longer follow-up effects of a more intense
stimulation protocol. All participants completed the study, with
only one male subject complaining sleepiness. At the clinical
observation, during the rTMS treatment (from the baseline until
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the fourth week), symptoms were attenuated for most patients,
eliminated for four, while they remained unvaried for six patients.
Importantly, CGI scores decreased at the end of week 4. YGTSS
scores decreased during the first 2 weeks and persisted until the
end of week 4. Furthermore, an improvement in mood, anxiety,
and attention disorders was observed. Importantly, both right
and left rMT increased over time. At the follow-up assessments,
19 out of 25 patients reported a clinical improvement until
the 3-month follow-up, while for 17 of them, the reported
improvements lasted until the 6-month follow-up evaluation.
Notably, by comparing the clinical measures for tics at YGTSS
and CGI obtained at week 4 with those obtained in the 3-
and 6-month follow-up evaluations, no differences were found,
indicating that the benefits of the 20 daily sessions of 1-
Hz rTMS on tics lasted for at least 6 months. Even if these
studies demonstrated a significant improvement in the clinical
symptoms of TS, the lack of a sham-control condition prevents
to rule out possible placebo effect.
SMA cTBS
To control for possible placebo effects, a recent study investigated
the effects of inhibiting SMA activity in TS/chronic tic disorders
patients, by using a randomized, double-blind, sham-controlled
design (Wu et al., 2014). In this study, functional fMRI was used
to provide individualized neuro-navigated rTMS stimulation of
SMA and to detect the treatment-related changes in SMA and
M1 activation during a motor task. Twelve participants with TS
were randomly assigned to the active (N = 6) or sham group
(N = 6). In the active condition, stimulation of the SMA was
delivered by using 30Hz cTBS at an intensity of 90% rMT.
This protocol was chosen since it was considered to be more
feasible with pediatric patients, with respect to 1-Hz LF-rTMS,
given that shorter duration and lower intensity of stimulation are
needed to induce similar effects. The cTBS pulses were delivered
in pattern of 3-pulse bursts repeated five times per second
for a total of 600 pulses per train. Four train of pulses were
daily delivered in 2 consecutive days. Unfortunately, there is
no information about the way in which sham stimulation was
delivered (nor about SMA localization). Primary clinical and
cortical outcome measures included the YGTSS total tic score
and the fMRI event-related signal in SMA and left- and right-
M1. Other clinical measures included the Gilles de la Tourette
Syndrome Quality of Life Scale (GTS-QOL), the Premonitory
Urge for Tics Scale (PUTS), the CY-BOCS, and DuPaul ADHD
Rating Scale. The clinical measures were taken at baseline
and 1 week after the end of the treatment, while the fMRI
scanning was performed before treatment and soon after the
second cTBS session. Patients were also videotaped, according
to the Rush Video-Based Tic Rating Scale, before and after the
2 day treatment and 1 week later. All participants completed
the study, with three participants complaining mild adverse
effects (abdominal pain, headaches, dry eyes), which resolved
spontaneously without medications. The clinical evaluation
showed that, although in each group 50% of patients had a
reduction of YGTSS score (of≥6 points), the active and the sham
groups did not differ with respect to tic reduction or to the other
clinical outcomes. However, after active cTBS, as compared to
sham, the fMRI activation during finger tapping was significantly
decreased in SMA and bilateral M1, thus highlighting the
possibility to induce desirable plastic changes in SMA and
M1 activity. However, the lack of significant clinical changes
points to the need to optimize the rTMS protocol in order to
maximize the clinical benefits and to test its effects in additional
randomized, double-blind, sham controlled studies with larger
TS samples. Moreover, direct measures of cortical inhibition
and excitation through paired-pulse TMS (Valls-Solé et al., 1992;
Kujirai et al., 1993; Tokimura et al., 1996) could provide more
valuable hints at the neurophysiological mechanisms involved
in the potential therapeutic effects of inhibitory rTMS protocols
for TS.
Dyslexia
Developmental dyslexia is a neurodevelopmental condition
featured by persistent difficulty in learning to read, which cannot
be explained by a deficit in sensory or cognitive functions, or by
a lack of motivations or of adequate instruction. With respect to
typical reading, developmental dyslexia has been associated with
hypoactivation of the left parieto-temporal regions, left occipito-
temporal regions, and with hyper-activation of the inferior
frontal regions. Standard remediation methods are based on
cognitive training programs that focus on the deficient aspects
of reading skills. These trainings often improve reading, while
they modify activation in critically involved brain areas, pointing
to compensatory processes. Importantly, the benefits induced
by conventional cognitive trainings are rarely stable over time
and they are rarely associated with full restitution, leading to
negative consequences in several functional everyday-life skills
and occupational difficulties. A possible progress in the treatment
of this disorder could be achieved by the integration of these
cognitive trainings with NIBS techniques (Vicario and Nitsche,
2013b), to foster the activation of the areas that are involved
in compensatory processes in dyslexia. In this vein, the use of
tDCS has been proposed (Vicario andNitsche, 2013b; Cancer and
Antonietti, 2018) and three recent double-blind, sham controlled
studies assessed the effects of enhancing left parieto-temporal
activation with anodal tDCS. No studies for the treatment
of dyslexia with other NIBS techniques have been conducted
so far.
tDCS
Bilateral Parieto-Temporal tDCS
In a first study, Costanzo et al. (2016a) investigated how
enhancing the activation of the hypoactive parieto-temporal
region could improve reading abilities in dyslexic patients.
A sample of 19 children and adolescents with dyslexia was
recruited. Participants were included if they were 1.5 SDs below
the age-matched population mean for speed or accuracy in
reading texts, words, or non-words, without any comorbidity
and familiarity for ADHD, epilepsy, or other neurological
diseases. The design included four conditions, presented in
counterbalanced order with a minimum interval of 24 h: in
two active conditions 1-mA tDCS was delivered for 20min
over bilaterally parieto-temporal areas (in the midway between
P7/8 and TP7/8) with (i) anodal left/cathodal right or (ii)
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cathodal left/anodal right montages; two control conditions
included (iii) a sham stimulation during which constant direct
current of 1mA was delivered for only 30 s with the anodal
left/right cathodal montage; (iv) a baseline condition without
tDCS. Neuropsychological testing of reading abilities included:
aloud reading of words, non-words, and text, lexical decision,
phoneme blending, verbal N-back, and rapid, automatized
naming tasks. These measures were taken 20min after the end
of each stimulation and at baseline. Importantly, symptoms and
side-effects of the stimulation were assessed though standard
questionnaire, listing several possible adverse sensations that
participants were asked to quantify, in terms of intensity
(absent, mild, moderate, severe). All participants completed the
study, no participants reported significant discomfort, acute
mood change or other psychological symptoms. Only tingling,
hitching, burning sensations, and sleepiness were reported, thus
indicating that, generally, the stimulation was well-tolerated.
The main findings of this study consisted in an improvement,
after left anodal/right cathodal parieto-temporal montage, in
text reading accuracy with respect to the others conditions.
Conversely, a performance worsening was found after left
cathodal/right anodal parieto-temporal tDCS. In the other
reading-related measures, no significant effect of stimulation was
found.
In a second study (Costanzo et al., 2016b), the effects of a
longer stimulation protocol, combined with a cognitive training,
were tested on a sample of 18 children and adolescents who were
randomly assigned to one of two groups: the left anodal/right
cathodal parieto-temporal active tDCS group, and the left
anodal/right cathodal parieto-temporal sham tDCS group. The
stimulation protocol lasted 6 weeks, during which eighteen 20-
minutes sessions of 1-mA tDCS were delivered (three times
a week with a minimum interval of 48 h between sessions).
Active or sham stimulation was delivered in combination with a
cognitive reading training consisting in 10min of tachistoscopic
presentation of verbal stimuli to improve reading speed and
in 10min of phonologic training, focused on letter-sound rules
to improve reading accuracy. Outcome reading abilities were
measured in terms of accuracy and speed in aloud reading of low-
and high-frequency word and non-word stimuli. These reading
abilities were assessed, before, immediately after, and 1 month
after the end of the treatment. Also in this case, the occurrence
of any adverse effects were tested, with no participants stopping
the treatment or claiming major discomfort. Tingling, itching,
burning sensations of local redness were reported. Of interest,
the authors found that, after the active-, but not after the sham-
tDCS, reading errors for low-frequency words and reading speed
for non-words were significantly reduced, and the improvement
persisted in the follow-up evaluation 1 month later. This 18-
session protocol has been recently applied (Costanzo et al., 2018)
on 26 participants to assess the effects immediately after, 1 month
and 6 months after the end of the intervention. While controlling
for chronological age, the authors found that, at all assessment
time points, only the active group improved reading efficiency
abilities for non-words, Furthermore, reading efficiency abilities
for low-frequency words increased 1 and 6 months after the
treatment, while controlling for chronological age and baseline
reading abilities. Even if stronger evidence is needed and
larger samples should be tested before drawing any conclusion,
results from these studies provide a starting point for future
investigations and interventions on learning disabilities with
tDCS.
Future Directions
The possibility to boost the rehabilitation of neurodevelopmental
disorders through NIBS is not exclusively limited to the use
or TMS or tDCS. Other techniques are, indeed, available, and
several attempts in their use have been proposed (Jin and
Kong, 2016; Looi et al., 2017). Particularly, transcutaneous vagus
nerve stimulation (tVNS) has been advised as a novel non-
invasive tool for neuromodulation (Ventureyra, 2000). tVNS
allows the stimulation of the vagus nerve and the brain through
transcutaneous electrical stimulation of the sensory afferent
auricular branch of the vagus nerve, in the cymba conchae. The
vagus nerve represents a key component of the parasympathetic
nervous system and it is involved in autonomic regulation.
During tVNS, afferent signals propagate to the nucleus of
the solitary tract and to the locus coeruleus and the raphe
nuclei (Kraus et al., 2007; Dietrich et al., 2008; Kreuzer et al.,
2012; Frangos et al., 2015). From there, signals are projected
to other subcortical and higher-order cortical structures (i.e.,
PFC, insula, limbic system). Although the precise mechanism
of tVNS is not yet completely understood, tVNS seems to
engage the same pathway of invasive VNS (Assenza et al.,
2017) and to enhance noradrenergic (Ventura-Bort et al., 2018),
and GABAergic functions (Capone et al., 2015). Thus, even if
stimulation during tVNS is not applied transcranially to the scalp,
as for TMS or tDCS, but transcutaneously to the ear, it directly
affects the activation of the vagus nerve, which propagates
to subcortical, and cortical brain structures, thus providing a
way of bottom-up modulation of neural activity. In spite of
the potential interest of using tVNS for neuromodulation in
neurodevelopmental disorders, no studies were identified that
have attempted its use with this population. Nevertheless, Jin
and Kong (2016) summarized in four points the rationale for
applying tVNS to treat ASD. Firstly, vagus nerve activity can
modulate emotional social interaction and repetitive behaviors
in children (Porges, 2007), while low vagal activity has been
often reported in ASD (Porges, 2001; Ming et al., 2005). By
increasing vagus nerve activity trough tVNS, an improvement
in the core symptoms of ASD is expected. The second point
is linked to the notion of abnormal functioning connectivity
between regions associated with facial expression processing,
emotional, and social communication as one of the possible
mechanisms of social dysfunction and repetitive behavior in
ASD (Cheng et al., 2015). Since tVNS can activate multiple
brain areas involved in social and emotional regulation (Frangos
et al., 2015), it could regulate the core symptoms of ASD. Third,
accumulating evidence suggests that ASD is associated with
dysfunctional immune responses, with increased inflammatory
responses associated to more impaired communication, and
aberrant behaviors (Ashwood et al., 2011). Crucially, tVNS
can modulate immune function through a downregulation of
inflammatory cytokine release (Lerman et al., 2016), suggesting
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a possible effect in mitigating ASD symptoms. Lastly, the efficacy
of invasive VNS in treating conditions comorbid to ASD (e.g.,
epilepsy and depression) has been widely demonstrated (George
et al., 2000) and a growing number of studies is confirming
the effectiveness of non-invasive tVNS for the same conditions
(Stefan et al., 2012; Fang et al., 2016). Crucially, the effects
of tVNS on epilepsy seem to be mediated by enhancement in
brain GABA levels (Capone et al., 2015). Thus, tVNS may have
implications also for the altered GABA transmission in ASD
(Bozzi et al., 2018). In spite of these converging theoretical
supports, empirical evidence on the effectiveness of tVNS in ASD
is still missing. Furthermore, possible advantages can also be
linked to the use of tVNS to reduce cortico-spinal excitability
and increase intracortical inhibition in TS, but no studies still
exist.
Another possibility resides in the use of transcranial Random
Noise Stimulation (tRNS) to improve learning disorders. TRNS
is a variant of TES and consists in the application of current at
quickly varying frequency bands (from 100 to 640Hz), delivered
through two electrodes and resulting in the simultaneous and
long-lasting excitation of the regions underlying the electrodes
(Terney et al., 2008). tRNS is thought to increase, via stochastic
resonance, weak signal detection while adding noise (Terney
et al., 2008; van der Groen and Wenderoth, 2016) and has
been viewed as suitable to enhance learning in mathematical
disabilities (Krause and Cohen Kadosh, 2013). In this vein, a
sham-controlled between-subject study (Looi et al., 2017) tested
the effects of 9 days of bilateral DLPFC tRNS (0.75mA, 0.1–
500Hz) coupled with a cognitive numerical training in 12
children (aged 9.5 ± 0.6 years) having mathematical learning
disabilities. The authors found that participants receiving real
tRNS improved performance in the mathematical training more
than those receiving sham tRNS. They also found a positive
correlation between the improved performance in the training
and mathematical, but not control working memory abilities,
suggesting a transfer of the effects. Despite the lack of other
records of tRNS used for pediatric population and the limited
sample of this study, results seem to encourage this line of
research.
CONCLUSIONS
Here we reviewed the available literature about the effects
of rTMS and tDCS in children and adolescents with
neurodevelopmental disorders. The review was focused on
the studies exploring the therapeutic effects of these NIBS
techniques. In general, the studies support the use of NIBS
as a treatment tool for neurodevelopmental disorders, by
showing in general positive effects of the treatment, particularly
when combined with functional cognitive training, and high
compliance with the treatment by children and their families.
Despite this, several methodological issues hampered the
relevance of these findings. Firstly, studies are mostly hampered
by small sample sizes and inconsistent use of sham (placebo)
protocols. The effects of practice, spontaneous changes over
time, and placebo effects make difficult to take clear conclusions
about the efficacy of many of the revised protocols. Secondly,
these studies raised questions about the long-term efficacy
of the treatment and their generalizability to everyday life. It
is thus necessary to investigate the short but also the lasting
effects of NIBS. Thirdly, considering the huge heterogeneity
of the symptoms in neurodevelopmental disorders, researches
involving more representative and uniform samples are needed,
to rule out that confounding factors may mask the efficacy
of the protocols on the intended outcome measures. Lastly,
despite the heterogeneity of the target populations, most NIBS
studies have focused on the DLPFC, varying the specific type
of stimulation protocol and the targeted cognitive function.
Systematic studies about the optimal stimulation protocols based
on the pathophysiology of the specific disease and the age of
the target population are, thus, urgently needed. Furthermore,
online monitoring of the neurophysiological effects of the
stimulation is required for safety purposes and to better interpret
the neurobiological mechanisms of action.
Importantly, implications for the immature brain’s response
to stimulation should be borne in mind while designing pediatric
NIBS protocols, in vein of possible side effects. Children and
adolescents might have accelerated neural plasticity compared to
adults after brain stimulation (Brunoni et al., 2012). Therefore,
NIBS is expected to have even greater potential to regulate
and enhance plasticity in children. At the same time, extreme
caution is needed while dealing with a developing brain, mainly
because of the lack of translational studies from adults to children
(Cohen Kadosh et al., 2012). Indeed, rather than considering it
as a small adult brain, a child’s brain has to be considered as
a unique physiological entity, and extreme diligence is required
while carrying out NIBS studies (Davis, 2014; Maslen et al.,
2014).
Importantly, feasibility, safety, and limitations of NIBS in
pediatric population have been reviewed in several ad hoc studies
(Quintana, 2005; Rajapakse and Kirton, 2013; Andrade et al.,
2014; Bikson et al., 2016; Allen et al., 2017; Hameed et al.,
2017). These studies suggest good safety and tolerability of
TMS and tDCS in children and adolescents with various brain
diseases, with <0.5% reporting a serious event during rTMS
(Allen et al., 2017) and only mild or minimal adverse effects
reported after different TMS (Rajapakse and Kirton, 2013; Hong
et al., 2015) and tDCS (Bikson et al., 2016) protocols. Practical
considerations, based on current flow modeling, should include
potentials modification of dosing and ad hoc localization of
the target brain areas. Moreover, experiment including children
with neurodevelopmental disorders may still require additional
clinical guidance, especially screening for at-risk medications
and potential seizures participants. Additional system and
techniques for recording side-effects, potential adverse events,
and tolerability are required. It is moreover important to
encourage authors to report in a systematic manner the safety
data, and to use standardized questionnaires to assess symptoms
or side effects (Brunoni et al., 2011). Lastly, even if the potential
of NIBS for a developing brains is debated, distinguishing the use
of NIBS in order to treat a pathology that threatens the child’s
well-being and the use of NIBS to enhance brain function in the
general pediatric population is deserved (Maslen et al., 2014).
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All in all, overviewing the use of NIBS in neurodevelopmental
disorders reveals the feasibility and promising efficacy of NIBS to
support neural plasticity and to reinforce the benefits of cognitive
trainings.
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